Evaluation of pharmacokinetic parameters of critically ill patients and simulation of dosing regimens required by Bayesian Therapeutic Drug Monitoring of fluconazole

被引:0
作者
Matusik, E. [1 ]
Bienvenu, A. L. [1 ]
Pradat, P. [2 ]
Rimmele, T. [3 ]
Pirriou, V. [4 ]
Gagnieu, M. C. [5 ]
Parent, F. [5 ]
Tod, M. [1 ]
Leboucher, G. [1 ]
Goutelle, S. [1 ]
机构
[1] Hosp Civils, Groupement Hosp Nord, Serv Pharm Pharmacol, Lyon, France
[2] Univ Lyon, ICBMS CNRS5246, Campus Lyon Tech Doua, Lyon, France
[3] Hosp Civils, Groupement Hosp Sud, Serv Anesthesie Reanimat, Lyon, France
[4] Hosp Civils, Groupement Hosp Ctr, Serv dAnesthesie Reanimat, Lyon, France
[5] Hosp Civils, Groupement Hosp Sud, Lab Biochim & Biol Mol, UM Pharmaco Toxicol, Lyon, France
关键词
therapeutic drug monitoring; fluconazole; antifungal agent; pharmacokinetics; invasive candidiasis;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PM2-010
引用
收藏
页码:75 / 76
页数:2
相关论文
共 1 条
  • [1] Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients
    Boonstra, J. M.
    Martson, A. G.
    Sandaradura, I
    Kosterink, J. G. W.
    van der Werf, T. S.
    Marriott, D. J. E.
    Zijlstra, J. G.
    Touw, D. J.
    Alffenaar, J. W. C.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (03)